Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: ENOV )

46.03 +1.98 (+4.49%)
Official Closing Price Updated: 7:00 PM EDT, Aug 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 380,501
Open 44.34
Bid (Size) 45.49 (1)
Ask (Size) 46.38 (1)
Prev. Close 44.05
Today's Range 43.99 - 46.15
52wk Range 39.98 - 65.03
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
First surgeries using EMPOWR Revision Knee™ with EMPOWR™ Cones successfully completed by design consultants Dr. Beau Kildow and Dr. Leonard T. Buller. 
From Enovis Corporation
Via GlobeNewswire
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
Revolutionary Scandinavian Total Ankle Replacement (STAR® Ankle) System Now Includes Vitamin E-Blended Polyethylene Insert 
From Enovis Corporation
Via GlobeNewswire

Performance

YTD
-16.97%
-16.97%
1 Month
-1.88%
-1.88%
3 Month
-7.42%
-7.42%
6 Month
-25.23%
-25.23%
1 Year
-17.91%
-17.91%

More News

Read More
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Critical Insights From Enovis Analyst Ratings: What You Need To Know
Via Benzinga
A Closer Look at 6 Analyst Recommendations For Enovis
Via Benzinga
ENOV Stock Earnings: Enovis Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Enovis Announces Second Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
From Enovis Corporation
Via GlobeNewswire
Earnings Outlook For Enovis
Via Benzinga
5 Analysts Have This To Say About Enovis
Via Benzinga
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
From Enovis Corporation
Via GlobeNewswire
Top 3 Health Care Stocks That Could Blast Off In June
Via Benzinga
5 Medical Info Systems Stocks To Buy For Stable Returns
Via Talk Markets
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
ENOV Stock Earnings: Enovis Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Enovis Announces First Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
Via Benzinga
Topics Earnings
Exposures Financial
Enovis Announces Fourth Quarter and Full Year 2023 Results
From Enovis Corporation
Via GlobeNewswire
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
From Enovis Corporation
Via GlobeNewswire
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
From Enovis Corporation
Via GlobeNewswire
Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
From Enovis Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.